Memorial Sloan-Kettering Cancer CenterのEmily Cheng 研究室では、現在Postdoctoral Fellow 及びResearch Associateを募集しております。当研究室では、BCL-2ファミリーによる細胞死制御機構の解明、及びBCL-2ファミリーを標的とした新規癌治療法の確立を目指して研究をおこなっています。応募される方は、以下の英文広告をご参照の上、Dr. ChengまでCV及び推薦者3名の連絡先リストをお送りください。なお、日本語でのご質問等ございましたら、当研究室出身の山内茜(ainoyama24@gmail.com)までお気軽にお問合せ下さい。

------
Postdoctoral fellow and research associate positions are available for highly motivated individuals interested in studying the BCL-2 family and the fundamental mechanisms of apoptosis, necroptosis, pyroptosis, and ferroptosis, interrogating the impact of cell death on tumor-immune crosstalk and immunotherapy, and investigating the molecular control of mitochondrial metabolism by the BCL-2 family (Science 330: 1390-1393; Molecular Cell 36: 487-499; Nature Cell Biology 8: 1348-1358; Nature Cell Biology 17: 1270-1281; Nature Communications 7: 13131; Cell Reports 21, 2926–2939). We are particularly interested in the pathogenesis and immunotherapy of lung and kidney cancers.

Applicants should hold a Ph.D. degree and have a strong background in molecular/cellular biology, biochemistry, mouse genetics, or cancer biology, and a good publication record.

Full applications including curriculum vitae and a list of three references should be submitted through chenge1@mskcc.org to: Emily Cheng, M.D., Ph.D., Member & Professor, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA.